Marika Sulashvili
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Marika Sulashvili has a total of 40 co-authors. Here are the top co-authors by number of shared publications:
- Margarita Beglaryan
Yerevan State Medical University after Mk. Heratsi, Yerevan, Republic of Armenia
3 shared publications - Nino Abuladze
Akaki Tsereteli State University, Georgia
3 shared publications - Nodar Sulashvili
Tbilisi State Medical University, Tbilisi, Georgia
3 shared publications Ada (Adel) Tadevosyan
Yerevan State Medical University after Mkhitar Heratsi; International Academy of Sciences of Ecology and Life Safety (MANEB); Law Academy; Association of Psychiatrists of Armenia; World Association of Psychiatrists; International Association for Traumatic Stress; World Association for Biological Psychiatry; International Association “Stress and Behavior”; Tbilisi, Georgia – Yerevan, Armenia – Los Angeles, USA
2 shared publications- David Aphkhazava
The University of Georgia, Tbilisi, Georgia
2 shared publications - Maka Buleishvili
Georgian International University (GIU), Faculty of Medicine, Tbilisi, Georgia
2 shared publications
Latest Publications
- Open Access
- 16 September 2026
- Published by Public Health Institute of Georgia in Georgian Medical Journal
- Vol. 1 (4)
Multidisciplinary Clinical Pharmacology in Complex Pharmacotherapy: Drug-Related Errors, Pharmacovigilance, and Evidence-Based Strategies for Medication Safety—A Systematic Review and Meta-Analysis
Background: Complex pharmacotherapy has become a defining feature of modern clinical care, particularly in older adults, patients with multimorbidity, and those moving across care settings. As the number of prescribed medicines increases, so does the risk of drug-related errors, adverse drug reactions, inappropriate prescribing, and preventable medication-related harm. Clinical pharmacology offers a practical bridge between therapeutic complexity and safer prescribing, monitoring, and deprescribing. This systematic review and meta-analysis synthesizes evidence on the burden, determinants, and prevention of medication-related harm in complex pharmacotherapy. Methods: We conducted a systematic review and meta-analysis in accordance with PRISMA guidelines. Electronic databases including PubMed/MEDLINE, Embase, Scopus, Web of Science, and Cochrane Library were searched from inception to 2024. Eligible studies included observational studies reporting medication-related errors, adverse drug events, or drug-related hospital use in adults exposed to polypharmacy (≥5 concurrent medicines) or complex pharmacotherapy, alongside interventional studies evaluating medication safety strategies. Risk of bias was assessed using design-specific tools (Newcastle-Ottawa Scale, Cochrane ROB, ROBINS-I), and evidence certainty was graded using GRADE. Random-effects meta-analyses were performed where clinical and methodological homogeneity permitted. Results: From 2,847 initially identified records, 87 studies met inclusion criteria, with 42 contributing to quantitative synthesis. The pooled prevalence of preventable medication harm was 3.0% (95% CI 2.4–3.6%), with higher rates in intensive care (5.2%) and older adults (4.1%). Polypharmacy prevalence among older adults was 41.4%, with adverse drug reaction frequencies increasing from 11.5% (2–5 medications) to 16.9% (≥5 medications). Potentially inappropriate prescribing affected 34.2% of older adults and was significantly associated with adverse drug events (OR 1.26, 95% CI 1.11–1.44). Medication discrepancies occurred in 53.7% of patients during care transitions, with discharge discrepancies doubling 30-day readmission risk (RR 2.12, 95% CI 1.76–2.55). Pharmacist-led reconciliation reduced adverse drug event-related hospital revisits by 67% (RR 0.33, 95% CI 0.20–0.53). Multicomponent interventions demonstrated the largest effects (medication errors RR 0.28, 95% CI 0.18–0.44), with favorable cost-effectiveness profiles ($2,500–$5,000 per QALY gained). Conclusion: Medication safety in complex pharmacotherapy is best approached as a systems problem rather than a single-prescriber issue. Evidence supports clinically grounded, pharmacology-informed strategies centered on structured medication review, safer transitions of care, stronger pharmacovigilance, and multidisciplinary stewardship. These findings are directly relevant to health systems in Georgia and the wider region, where aging populations, multimorbidity, and fragmented care increasingly converge. Keywords: Complex Pharmacotherapy; Medication Safety; Polypharmacy; Pharmacovigilance; Drug-Related Errors; Systematic Review.
- 16 September 2026
- Published by Public Health Institute of Georgia in Georgian Medical Journal
- Vol. 1 (4)
Open AccessMultidisciplinary Clinical Pharmacology in Complex Pharmacotherapy: Drug-Related Errors, Pharmacovigilance, and Evidence-Based Strategies for Medication Safety—A Systematic Review and Meta-Analysis
Background: Complex pharmacotherapy has become a defining feature of modern clinical care, particularly in older adults, patients with multimorbidity, and those moving across care settings. As the number of prescribed medicines increases, so does the risk of drug-related errors, adverse drug reactions, inappropriate prescribing, and preventable medication-related harm. Clinical pharmacology offers a practical bridge between therapeutic complexity and safer prescribing, monitoring, and deprescribing. This systematic review and meta-analysis synthesizes evidence on the burden, determinants, and prevention of medication-related harm in complex pharmacotherapy. Methods: We conducted a systematic review and meta-analysis in accordance with PRISMA guidelines. Electronic databases including PubMed/MEDLINE, Embase, Scopus, Web of Science, and Cochrane Library were searched from inception to 2024. Eligible studies included observational studies reporting medication-related errors, adverse drug events, or drug-related hospital use in adults exposed to polypharmacy (≥5 concurrent medicines) or complex pharmacotherapy, alongside interventional studies evaluating medication safety strategies. Risk of bias was assessed using design-specific tools (Newcastle-Ottawa Scale, Cochrane ROB, ROBINS-I), and evidence certainty was graded using GRADE. Random-effects meta-analyses were performed where clinical and methodological homogeneity permitted. Results: From 2,847 initially identified records, 87 studies met inclusion criteria, with 42 contributing to quantitative synthesis. The pooled prevalence of preventable medication harm was 3.0% (95% CI 2.4–3.6%), with higher rates in intensive care (5.2%) and older adults (4.1%). Polypharmacy prevalence among older adults was 41.4%, with adverse drug reaction frequencies increasing from 11.5% (2–5 medications) to 16.9% (≥5 medications). Potentially inappropriate prescribing affected 34.2% of older adults and was significantly associated with adverse drug events (OR 1.26, 95% CI 1.11–1.44). Medication discrepancies occurred in 53.7% of patients during care transitions, with discharge discrepancies doubling 30-day readmission risk (RR 2.12, 95% CI 1.76–2.55). Pharmacist-led reconciliation reduced adverse drug event-related hospital revisits by 67% (RR 0.33, 95% CI 0.20–0.53). Multicomponent interventions demonstrated the largest effects (medication errors RR 0.28, 95% CI 0.18–0.44), with favorable cost-effectiveness profiles ($2,500–$5,000 per QALY gained). Conclusion: Medication safety in complex pharmacotherapy is best approached as a systems problem rather than a single-prescriber issue. Evidence supports clinically grounded, pharmacology-informed strategies centered on structured medication review, safer transitions of care, stronger pharmacovigilance, and multidisciplinary stewardship. These findings are directly relevant to health systems in Georgia and the wider region, where aging populations, multimorbidity, and fragmented care increasingly converge. Keywords: Complex Pharmacotherapy; Medication Safety; Polypharmacy; Pharmacovigilance; Drug-Related Errors; Systematic Review.
- Open Access
- 22 July 2026
- Published by MDPI AG in Preprints.org
Scientific Perspectives on the Synergy Between Environmental Engineering and Eco-Urbanism: Enabling Adaptive, Low-Carbon, and Climate-Resilient Regenerative, and Sustainable Urban Systems Through Integrated Ecological Innovation
The accelerating pressures of climate change, rapid urbanization, resource depletion, and environmental degradation necessitate the development of integrative and forward-looking paradigms for sustainable urban transformation. This study explores the scientific perspectives underpinning the synergy between environmental engineering and eco-urbanism, emphasizing their collective potential to enable adaptive, low-carbon, and resilient urban systems. Environmental engineering, traditionally focused on pollution control, resource management, and infrastructure optimization, is increasingly intersecting with eco-urbanism, a multidisciplinary framework that prioritizes ecological integrity, human well-being, and sustainable spatial planning. The convergence of these domains fosters a systems-oriented approach to urban development, wherein technological innovation, ecological design, and socio-economic considerations are harmonized. This paper critically examines contemporary theoretical frameworks, methodological approaches, and practical implementations that exemplify this synergy. It highlights the role of advanced environmental engineering solutions—such as green infrastructure, decentralized water and wastewater treatment systems, renewable energy integration, and circular resource management—in shaping eco-urbanistic strategies. Simultaneously, eco-urbanism contributes spatial, architectural, and policy-oriented dimensions that enhance the functionality and scalability of engineered systems within complex urban environments. The interplay between these fields supports the transition from linear, resource-intensive urban models toward regenerative and circular urban metabolisms. Particular attention is given to adaptive capacity and resilience, which are increasingly recognized as essential attributes of sustainable cities. The integration of smart technologies, data-driven decision-making, and climate-responsive design enables urban systems to anticipate, absorb, and recover from environmental and socio-economic shocks. Moreover, low-carbon development pathways are explored through the lens of energy-efficient infrastructure, sustainable mobility systems, and nature-based solutions that collectively reduce greenhouse gas emissions while enhancing urban livability. The study also addresses key challenges and limitations associated with the implementation of synergistic approaches, including governance fragmentation, financial constraints, technological disparities, and the need for interdisciplinary collaboration. It underscores the importance of policy coherence, stakeholder engagement, and capacity building in facilitating the effective integration of environmental engineering principles within eco-urbanistic planning frameworks. Furthermore, emerging trends such as digital urbanism, climate-neutral cities, and biomimetic design are discussed as critical enablers of future urban sustainability. The scientific synergy between environmental engineering and eco-urbanism represents a transformative pathway toward sustainable urban futures. By integrating technical expertise with ecological and socio-spatial considerations, this approach provides a robust foundation for the development of adaptive, low-carbon, and resilient urban systems capable of addressing the complex challenges of the 21st century.
- 22 July 2026
- Published by MDPI AG in Preprints.org
Open AccessScientific Perspectives on the Synergy Between Environmental Engineering and Eco-Urbanism: Enabling Adaptive, Low-Carbon, and Climate-Resilient Regenerative, and Sustainable Urban Systems Through Integrated Ecological Innovation
The accelerating pressures of climate change, rapid urbanization, resource depletion, and environmental degradation necessitate the development of integrative and forward-looking paradigms for sustainable urban transformation. This study explores the scientific perspectives underpinning the synergy between environmental engineering and eco-urbanism, emphasizing their collective potential to enable adaptive, low-carbon, and resilient urban systems. Environmental engineering, traditionally focused on pollution control, resource management, and infrastructure optimization, is increasingly intersecting with eco-urbanism, a multidisciplinary framework that prioritizes ecological integrity, human well-being, and sustainable spatial planning. The convergence of these domains fosters a systems-oriented approach to urban development, wherein technological innovation, ecological design, and socio-economic considerations are harmonized. This paper critically examines contemporary theoretical frameworks, methodological approaches, and practical implementations that exemplify this synergy. It highlights the role of advanced environmental engineering solutions—such as green infrastructure, decentralized water and wastewater treatment systems, renewable energy integration, and circular resource management—in shaping eco-urbanistic strategies. Simultaneously, eco-urbanism contributes spatial, architectural, and policy-oriented dimensions that enhance the functionality and scalability of engineered systems within complex urban environments. The interplay between these fields supports the transition from linear, resource-intensive urban models toward regenerative and circular urban metabolisms. Particular attention is given to adaptive capacity and resilience, which are increasingly recognized as essential attributes of sustainable cities. The integration of smart technologies, data-driven decision-making, and climate-responsive design enables urban systems to anticipate, absorb, and recover from environmental and socio-economic shocks. Moreover, low-carbon development pathways are explored through the lens of energy-efficient infrastructure, sustainable mobility systems, and nature-based solutions that collectively reduce greenhouse gas emissions while enhancing urban livability. The study also addresses key challenges and limitations associated with the implementation of synergistic approaches, including governance fragmentation, financial constraints, technological disparities, and the need for interdisciplinary collaboration. It underscores the importance of policy coherence, stakeholder engagement, and capacity building in facilitating the effective integration of environmental engineering principles within eco-urbanistic planning frameworks. Furthermore, emerging trends such as digital urbanism, climate-neutral cities, and biomimetic design are discussed as critical enablers of future urban sustainability. The scientific synergy between environmental engineering and eco-urbanism represents a transformative pathway toward sustainable urban futures. By integrating technical expertise with ecological and socio-spatial considerations, this approach provides a robust foundation for the development of adaptive, low-carbon, and resilient urban systems capable of addressing the complex challenges of the 21st century.
- Open Access
- 22 June 2023
- Published by Apex Publishing in Journal of Composites and Compounds
- Vol. 5 (15) , 74-90
Recent advances in nanocarrier-based targeted drug delivery: For lung, colon, and breast cancers
- 22 June 2023
- Published by Apex Publishing in Journal of Composites and Compounds
- Vol. 5 (15) , 74-90
Open AccessRecent advances in nanocarrier-based targeted drug delivery: For lung, colon, and breast cancers
- Open Access
- 31 March 2023
- Published by Private Company Technology Center in ScienceRise: Biological Science
- No. 1(34),p. 19-30
The manifestation of features of opioids and narcotics using by drug addicted people and the role of replacement pharmacotherapy in treatment and recovery of the patient
Aim of the research was to study and analyze the features of opioids and narcotics using by drug addicted people and the role of replacement drugs in treatment and recovery of the patient. Materials and methods: We conducted a systematic review and meta-analysis of studies. Were used Systematic literature reviews and meta-analyses. The material of the article was data from the scientific literature, processed and analyzed by generalization and systematization. The scientific research ensues the fundamentals of assessment development of significant reviews. The ensuing databases were used: (for searching considerable literature to study and analyze the features of opioids and narcotics using by drug addiction people and the role of replacement drugs in treatment and recovery of the patient) Pub Med, Web of Science, Clinical key, Tomson Routers, Google Scholar, Cochrane Library, and Elsevier bases. Additionally studied national and internationals policy and guidelines and also grey literature. Results: Addiction is well known to be associated with its high level of physical and mental disorders. Most chronic chemical dependencies of drug addiction are also associated with its very high mortality rates, estimated to be several times those of the non-clinical population. Since addictive substances are known to disrupt cell growth and cell division, it can be assumed, that they particularly affect dividing cells, such as stem cell pools and progenitor cells. It is also known, that they either individually or in combination potentiate apoptosis, i.e., contribute to this effect. The medicine of aging in recent times has become an independent scientific discipline. The cellular aging hypothesis suggests the aging phenotype. The organism is associated with cellular correlates of age associated changes including cell loss, reduced cell velocity, renewal and more aging, negligible functional and non-replicating cells in tissues. So, the anti-growth effects of drug addiction can reasonably occur throughout the body. Expect signs of accelerated aging to be evident. One would expect such a putative progeroid effect to occur subject to increased morbidity and mortality rates, clinically observed almost identically in drug addicts as is the case in the geriatric population. In this connection there are various changes, consideration of all clinical aspects’ expression of this general toxicology hypothesis of opioids is needed. Conclusion: Pharmacological management of drug use should be only one component of treatment for drug needs, tailored to a comprehensive needs assessment of the child or young person, carried out in conjunction with appropriate psychological therapy and mental health interventions, and in the context of a clear and applied approach to the clinical management system. Caution is required when leaving these establishments due to the risk of overdose and in the transition to adult services. Physicians should carefully consider the degree of dependence on any substance, especially when alcohol and other substances, such as opiates, are used together. The full implementation of treatment, rehabilitation and harm reduction services will reduce the negative health, social and economic consequences of drug use for individuals, communities and society as a whole. The number of drug users will increase, those involved in counseling, treatment, rehabilitation and harm reduction programs
- 31 March 2023
- Published by Private Company Technology Center in ScienceRise: Biological Science
- No. 1(34),p. 19-30
Open AccessThe manifestation of features of opioids and narcotics using by drug addicted people and the role of replacement pharmacotherapy in treatment and recovery of the patient
Aim of the research was to study and analyze the features of opioids and narcotics using by drug addicted people and the role of replacement drugs in treatment and recovery of the patient. Materials and methods: We conducted a systematic review and meta-analysis of studies. Were used Systematic literature reviews and meta-analyses. The material of the article was data from the scientific literature, processed and analyzed by generalization and systematization. The scientific research ensues the fundamentals of assessment development of significant reviews. The ensuing databases were used: (for searching considerable literature to study and analyze the features of opioids and narcotics using by drug addiction people and the role of replacement drugs in treatment and recovery of the patient) Pub Med, Web of Science, Clinical key, Tomson Routers, Google Scholar, Cochrane Library, and Elsevier bases. Additionally studied national and internationals policy and guidelines and also grey literature. Results: Addiction is well known to be associated with its high level of physical and mental disorders. Most chronic chemical dependencies of drug addiction are also associated with its very high mortality rates, estimated to be several times those of the non-clinical population. Since addictive substances are known to disrupt cell growth and cell division, it can be assumed, that they particularly affect dividing cells, such as stem cell pools and progenitor cells. It is also known, that they either individually or in combination potentiate apoptosis, i.e., contribute to this effect. The medicine of aging in recent times has become an independent scientific discipline. The cellular aging hypothesis suggests the aging phenotype. The organism is associated with cellular correlates of age associated changes including cell loss, reduced cell velocity, renewal and more aging, negligible functional and non-replicating cells in tissues. So, the anti-growth effects of drug addiction can reasonably occur throughout the body. Expect signs of accelerated aging to be evident. One would expect such a putative progeroid effect to occur subject to increased morbidity and mortality rates, clinically observed almost identically in drug addicts as is the case in the geriatric population. In this connection there are various changes, consideration of all clinical aspects’ expression of this general toxicology hypothesis of opioids is needed. Conclusion: Pharmacological management of drug use should be only one component of treatment for drug needs, tailored to a comprehensive needs assessment of the child or young person, carried out in conjunction with appropriate psychological therapy and mental health interventions, and in the context of a clear and applied approach to the clinical management system. Caution is required when leaving these establishments due to the risk of overdose and in the transition to adult services. Physicians should carefully consider the degree of dependence on any substance, especially when alcohol and other substances, such as opiates, are used together. The full implementation of treatment, rehabilitation and harm reduction services will reduce the negative health, social and economic consequences of drug use for individuals, communities and society as a whole. The number of drug users will increase, those involved in counseling, treatment, rehabilitation and harm reduction programs